The disproportionate burden of kidney disease in those who can least afford it

Kidney International, Supplement

Volumn 68, Issue 97, 2005, Pages

  Agodoa, Lawrence ^a   Norris, Keith ^a   Pugsley, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DEVELOPING COUNTRY; DISEASE COURSE; DISEASE SEVERITY; ECONOMIC ASPECT; EPIDEMIC; GLOMERULONEPHRITIS; HEALTH PROGRAM; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LIFESTYLE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLICY; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; RISK FACTOR; SOCIOECONOMICS; ULTRAFILTRATION; UNITED STATES; DISEASE ASSOCIATION; EDITORIAL; HEALTH STATUS; INCIDENCE; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; POPULATION RESEARCH; PREVALENCE; RENOVASCULAR HYPERTENSION; CHRONIC KIDNEY FAILURE; COST OF ILLNESS; ECONOMICS; KIDNEY; MINORITY GROUP; PATHOLOGY; REVIEW;

COST OF ILLNESS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MINORITY GROUPS; RISK FACTORS; UNITED STATES;

EID: 27744608841     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.09700.x     Document Type: Conference Paper

References (19)

1. POWE NR: To have and have not: Health and health care disparities in chronic kidney disease. Kidney Int 64:763-772, 2003
2. NICHOLAS S, AGODOA LY, NORRIS K: Ethnic disparities in the prevalence and treatment of kidney disease. Nephrol News Issues 18:29-30, 32, 34
3. DEPARTMENT OF HEALTH AND HUMAN SERVICES: Healthy People 2010 (http://www. healthypeople.gov)
4. STENGEL B, TARVER-CARR ME, POWE NR, et al: Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 14:479-487, 2003
5. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: Strategic Plan to Reduce and Eliminate Minority Health Disparities, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
6. UNITED STATES RENAL DATA SYSTEM: United States Renal Data System 2004 Annual Data Report. Atlas of End Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004
7. CHAKRAVARTHY MV, BOOTH FW: Eating, exercise, and "thrifty" genotypes: Connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol 96:3-10, 2004
8. LOPES AA, PORT FK: The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease. Am J Kidney Dis 25:350-356, 1995
9. PARVING HH, LEHNERT H, BROCHNER-MORTENSEN J, et al: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345, 870-878, 2001
10. LEWIS EJ, HUNSICKER LG, CLARKE WR, et al: Renoprotective effect of the angiotensin-receptor antagonist Ibesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345, 851-860, 2001
11. BRENNER BM, COOPER ME, DE ZEEUW D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345, 861-869, 2001
12. NORRIS KC, THORNHILL-JOYNES M, ROBINSON C, et al: Cocaine use, hypertension and end-stage renal disease. Am J Kidney Dis 38:523-528, 2001
13. PERNEGER TV, WHELTON PK, KLAG MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin and nonsteroidal anti-inflammatory drugs. N Engl J Med 331:1675-1679, 1994
14. SANDLER DP, SMITH JC, WEINBERG CR, et al: Analgesic use and chronic renal disease. N Engl J Med 320:1238-1243, 1989
15. NORRIS KC, THORNHILL-JOYNES M, TAREEN N: Cocaine use and chronic renal failure. Semin Nephrol 21:362-366, 2001
16. AGODOA LY, APPEL L, BAKRIS GL, et al, FOR THE AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK) STUDY GROUP: Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis. A randomized controlled trial. JAMA 285:2719-2728, 2001
17. WINSTON JS, BURNS GC, KLOTMAN PE: The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Semin Nephrol 18:373-377, 1998
18. KLOTMAN PE: HIV-associated nephropathy. Kidney Int 56:1161-1176, 1999
19. MONAHAN M, TANJI N, KLOTMAN PE: HIV-associated nephropathy: An urban epidemic. Semin Nephrol 21:393-402, 2001